News & Articles

In the fast-paced world of science, knowledge drives progress, and The Bio-Rad Academy leads the charge

The North Carolina-based study will continue to test enrolled newborns for hundreds of childhood-onset rare genetic conditions

Ribbon Bio Co-founder, Wladimir Labeikovsky, provides unique perspectives on synthetic DNA and discusses the company’s commitment to producing pure and accurate synthetic DNA molecules

Discover the latest technology to supercharge your gene therapy vector analysis workflow

Agilent Technologies, Thermo Fisher Scientific, and Tecan among those recognized

Explore the latest technologies and techniques that will help you advance biopharma pipelines

Explore ways to resolve three of the key challenges in the field of mRNA-based therapies

A survey exploring the science behind cell and gene therapies highlights the tech at the heart of this breakthrough area

Find out which lab products scientists are using to advance the field and what their experiences have been

Cast your vote for the new product that has made the most difference to your research for the chance to win a $500 Amazon Gift Card (or equivalent currency)

Authors successfully demonstrate transport of new-gene editing technology to ‘cut out’ HIV DNA from infected cells

Viral vector experts share AAV-based gene therapy manufacturing challenges and solutions

The collaboration delivers a walk-away solution suitable for high-throughput long-read sequencing in under two hours

New mRNA-based therapies and vaccines could be developed more quickly and cheaply thanks to new manufacturing technologies developed at the University of Sheffield

Explore how a nascent method for the precise production of CAR-T cells could pave the way for the next generation of cancer assassins

Discover how the Wellcome Sanger Institute is helping to develop a physical atlas of all human organs

Explore how the latest advancements and recent regulatory approvals are making truly personalized medicine a reality

Companies unite in shared vision of enabling researchers to translate genomic insights

As we celebrate the first regulatory approval of a gene-editing based therapeutic, Casgevy™, for the treatment of sickle cell disease and transfusion-dependent β-thalassemia, we consider the gene-editing challenges that must be overcome before CRISPR gene-editing technology becomes a common treatment modality

Automated workflows from single-cell dispensing to 3D spheroid analysis

Casgevy™ and Lyfgenia™ approvals pave the way for personalized gene editing therapies in treating sickle cell disease

Tell us which new products have had the biggest impact on your lab work for a chance to win a $500 Amazon.com Gift Card (or equivalent currency)